Fol. Biol. 2011, 57, 57-64
https://doi.org/10.14712/fb2011057020057
In Vitro Effects of Imatinib on Glucose-6-phosphate Dehydrogenase and Glutathione Reductase
References
1. , N. L., Tezcan, E. F. (1989) Sheep brain glutathione reductase: Purification and general properties. FEBS Lett. 250, 72-74.
<https://doi.org/10.1016/0014-5793(89)80687-8>
2. , J. V., Park, M. (2009) Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. Am. J. Physiol. Endocrinol. Metab. 296, 973-984.
<https://doi.org/10.1152/ajpendo.90857.2008>
3. , L. D., Veine, D. M., Williams, C. H. Jr. (2000) Mixed disulfide with glutathione as an intermediate in the reaction catalyzed by glutathione reductase from yeast and as a major form of the enzyme in the cell. Biochemistry 39, 4711-4721.
<https://doi.org/10.1021/bi9926431>
4. , M., Yamamoto, R., Iishi, H., Tatsuta, M., Wada, A. (1989) Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine. Int. J. Cancer 43, 892-895.
<https://doi.org/10.1002/ijc.2910430526>
5. , N. Z., Hothersall, J. S., McLean, P. (1988) Function and regulation of the pentose phosphate pathway in brain. Curr. Top. Cell. Regul. 29, 265–289.
<https://doi.org/10.1016/B978-0-12-152829-4.50008-2>
6. , K., Brewer, G. J., Kirkman, H. N., Luzzato, L., Motulsky, A. G., Ramot, B., Siniscalco, M. (1967) Standardized method for G-6-PD assay of haemolysates. WHO Tech. Rep. Ser. 366, 30-32.
7. , J., Cascante, M., Marin, S., Comín-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W. N., Boros, L.G. (2001) Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276, 37747-37753.
<https://doi.org/10.1074/jbc.M105796200>
8. , M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
<https://doi.org/10.1016/0003-2697(76)90527-3>
9. , M. P., Berry, A., Scrutton, N. S., Perham, R. N. (1989) Alternative proton donors/acceptors in the catalytic mechanism of the glutathione reductase of Escherichia coli: the role of histidine-439 and tyrosine-99. Biochemistry 28, 9602-9607.
<https://doi.org/10.1021/bi00451a008>
10. , C., Milne, J., Loveridge, N. (1993) Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase. Bone Miner. 22, 105-115.
<https://doi.org/10.1016/S0169-6009(08)80222-X>
11. , M., Biglia, N., Sismondi, P. (1991) Chemoresistance in breast tumors. Eur. J. Gynaecol. Oncol. 12, 359-373.
12. , F. J., DeAngelo, D. J., Baccarani, M., Deininger, M., Guilhot, F., Hughes, T., Mauro, M., Radich, J., Ottmann, O., Cortes, J. (2008) Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia. Semin. Oncol. 35, 1-17.
<https://doi.org/10.1053/j.seminoncol.2007.12.002>
13. , E. G., Korolova, E. Y., Egorova, N. I., Larionova, V. B., Garin, A. M., Kushlinskii, N. E. (1998) Role of glutathione-S-transferase in tumor drug resistance. Bull. Exp. Biol. Med. 125, 499-502.
<https://doi.org/10.1007/BF02445296>
14. , A. L., Hochhauser, D. (1992) Mechanisms of multidrug resistance in cancer treatment. Acta Oncol. 31, 205-213.
<https://doi.org/10.3109/02841869209088904>
15. , G. P., Argyrokastritis, A., Bizelis, I., Rogdakis, E. (2007) Cloning and characterization of an alternative transcript of ovine glucose 6-phosphate dehydrogenase gene: Comparative approach between ruminant and non-ruminant species. Gene 388, 93-101.
<https://doi.org/10.1016/j.gene.2006.10.016>
16. , J. A., Dam, A., Maron, B. A. (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med. 13, 189-197.
<https://doi.org/10.1038/nm1545>
17. , L. I., Wolf, C. R. (1999) Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resist. Updat. 2, 153-164.
<https://doi.org/10.1054/drup.1999.0083>
18. , C. E., Gover, S., Basak, A. K., Cosgrove, M. S., Levy, H. R., Adams, M. J. (2001) NADP+ and NAD+ binding to the dual coenzyme specific enzyme Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase: different interdomain hinge angles are seen in different binary and ternary complexes. Acta Crystallogr. D Biol. Crystallogr. 57, 635-648.
<https://doi.org/10.1107/S0907444901003420>
19. , A., Giordano, S. (2008) From singleto multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr. Med. Chem. 15, 422-432.
20. , C. D., Powell, S. R. (1984) Inhibition of cellular antioxidants: a possible mechanism of toxic cell injury. Environ. Health Perspect. 57, 307-311.
<https://doi.org/10.1289/ehp.8457307>
21. , S. V., Allen, T., Singh, R. (2002) Inevitable glutathione, then and now. Indian J. Exp. Biol. 40, 706-716.
22. Segel, I. H. (1975) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley & Sons, New York.
23. , C., Ulusu, N. N. (2007) Three different purification protocols in purification of G6PD from sheep brain cortex. FABAD J. Pharm. Sci. 32, 65-72.
24. , B., Ulusu, N. N. (2010) Purification and kinetics of bovine kidney cortex glutathione reductase. Protein Pept. Lett. 17, 667-674.
<https://doi.org/10.2174/092986610791112684>
25. , K. D. (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54, 4313-4320.
26. , W. N., Pignatare, J. N., Stanton, R. C. (1994) Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J. Biol. Chem. 269, 14798-14805.
<https://doi.org/10.1016/S0021-9258(17)36695-4>
27. , N. N., Kuş, M. S., Açan, N. L., Tezcan, E. F. (1999) A rapid method for the purification of glucose-6-phosphate dehydrogenase from bovine lens. Int. J. Biochem. Cell Biol. 31, 787-796.
<https://doi.org/10.1016/S1357-2725(99)00019-9>
28. , N. N., Tandogan, B. (2006) Purification and kinetics of sheep kidney cortex glucose-6-phosphate dehydrogenase. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 143, 249-255.
<https://doi.org/10.1016/j.cbpb.2005.11.018>
29. , R., Schirmer, R. H., Schirmer, I., Krauth-Siegel, R. L. (1981) Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FADbinding domain. Eur. J. Biochem. 120, 407-419.
<https://doi.org/10.1111/j.1432-1033.1981.tb05718.x>
30. , N. P., Gelderblom, H., Karlsson, M. O. (2007) Influence of cyp3a4 inhibition on the steady-state pharmacokinetics of imatinib. Clin. Cancer Res. 13, 7394-7400.
<https://doi.org/10.1158/1078-0432.CCR-07-0346>
31. , R. I., Haenen, G. R., Evelo, C. T., Bast, A. (2003) Effect of vitamin E on glutathione-dependent enzymes. Drug Metab. Rev. 35, 215-253.
<https://doi.org/10.1081/DMR-120024086>
32. , M., Mattern, J. (1996) Resistance mechanisms and their regulation in lung cancer. Crit. Rev. Oncog. 7, 227-244.
<https://doi.org/10.1615/CritRevOncog.v7.i3-4.50>
33. , M. (1998) Multidrug resistance and its reversal. Anticancer Res. 18, 2905-2917.
34. , S., Andre, C., Benning, C. (2008) Functional analyses of cytosolic glucose-6-phosphate dehydrogenases and their contribution to seed oil accumulation in Arabidopsis. Plant Physiol. 146, 277-288.
<https://doi.org/10.1104/pp.107.108423>
35. , M., Suzuki, H., Sugiyama, Y. (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm. Res. 13, 497-513.
<https://doi.org/10.1023/A:1016077517241>
